Zanubrutinib in Combination With Obinutuzumab (ZO) for Newly Diagnosed Follicular Lymphoma | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Zanubrutinib in Combination With Obinutuzumab (ZO) for Newly Diagnosed Follicular Lymphoma	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, follicular lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm	Recruiting	Phase 2	2024-09-03		NCT06553352

8 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Fujian Cancer Hospital	114
Huazhong University of Science and Technology	83
Jiangxi Provincial Cancer Hospital	33
Shanxi Province Cancer Hospital	43
Sun Yat-sen University	606
The First Affiliated Hospital of Xiamen University	107
The First Hospital of Jilin University	154
The Second Affiliated Hospital of Dalian Medical University	18

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Bing Xu	Xiamen	China	4